文献速递瓣膜外科

Cox-maze IV联合二尖瓣手术后永久起搏器植入率较高:全国注册研究

High incidence of permanent pacemaker after Cox-maze IV and mitral valve surgery: a nationwide registry-based study.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

瑞典全国注册回顾性分析显示,2009–2017年397例因症状性二尖瓣反流合并房颤接受CMIV加二尖瓣手术的患者,与2014–2017年346例单纯二尖瓣手术的房颤患者相比,早期起搏器植入率更高(13.3% vs 5.5%,P=0.002),8年调整后起搏器风险加倍(HR 1.96,95%CI 1.27–3.04);CMIV组5年22%、8年27%需起搏器,迟发起搏以窦房结功能障碍为主(48%)。

要点

  • CMIV加二尖瓣手术早期起搏器植入率13.3%,高于单纯二尖瓣手术的5.5%。
  • 8年调整后起搏器风险HR 1.96(95%CI 1.27–3.04)。
  • CMIV组迟发起搏器主要适应证为窦房结功能障碍(48%)。

核心结论

  • CMIV联合二尖瓣手术患者术后起搏器植入率高于单纯二尖瓣手术的房颤患者,迟发起搏主要因窦房结功能障碍。

研究设计与样本

  • 回顾性全国注册研究,CMIV加二尖瓣手术组397例(2009–2017年,瑞典),单纯二尖瓣手术房颤对照组346例(2014–2017年),随访至2022年9月30日。

主要发现

  • CMIV组早期(<30天)起搏器植入13.3%,对照组5.5%(P=0.002)。
  • 8年调整后起搏器风险HR 1.96(95%CI 1.27–3.04)。
  • CMIV组5年起搏器累积22%(95%CI 18–26%),8年27%(95%CI 22–31%);对照组两个时间点均为13%(95%CI 10–17%)。
  • 两组早期起搏适应证中二度/三度房室传导阻滞均占>60%;CMIV组迟发起搏中窦房结功能障碍占48%。

临床怎么用

  • CMIV联合二尖瓣手术术前应告知患者术后起搏器植入风险较高,并加强术后心律监测。

局限性

  • CMIV组平均年轻4岁且手术风险较低,组间基线存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study evaluated the long-term risk of permanent pacemaker implantation following Cox-maze IV (CMIV) and concurrent mitral valve surgery. METHODS: A retrospective, nationwide, registry-based analysis was conducted on postoperative permanent pacemaker implantation in 397 patients with symptomatic mitral valve insufficiency and atrial fibrillation who underwent CMIV and mitral valve surgery in Sweden between 2009 and 2017. They were compared to a registry group of 346 patients with atrial fibrillation who underwent mitral valve surgery without surgical ablation during 2014-2017. The follow-up ended on 30 September 2022. RESULTS: CMIV patients were on average 4 years younger and had lower surgical risk than registry patients. More CMIV patients underwent early (<30 days) pacemaker implantation (13.3% vs. 5.5%, P = 0.002). CMIV patients had a doubled adjusted risk of requiring a pacemaker compared to registry patients after 8 years [HR 1.96, 95% CI 1.27-3.04]. In the CMIV group, 22% (95% CI 18-26%) had a pacemaker by 5 years, increasing to 27% (95% CI 22-31%) by 8 years, compared to 13% (95% CI 10-17%) at both time intervals in the registry group. Atrioventricular block II/III accounted for >60% of early pacemaker indications in both groups, and sinus node dysfunction was the indication for late pacemaker implantation in 48% in the CMIV group. CONCLUSIONS: Patients undergoing CMIV concomitant with mitral valve surgery have a higher rate of postoperative pacemaker implantation compared to patients with atrial fibrillation undergoing mitral valve surgery alone. Sinus node dysfunction was the main indication for late pacemaker among CMIV patients.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ivert T, Boano G, Vanky F, et al. High incidence of permanent pacemaker after Cox-maze IV and mitral valve surgery: a nationwide registry-based study. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40184218. doi:10.1093/icvts/ivaf085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。